Crockett Thomas Andrew
Insider CIK 1690920 · KALV President and CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KALV KalVista Pharmaceuticals, | S Sale | 2024-02-20 | 2024-02-21 | 24,888 | $14.11 | $351.2K | 211,203 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-02-17 | 2024-02-21 | 20,833 | — | $0 | 20,834 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-02-17 | 2024-02-21 | 5,805 | — | $0 | 52,245 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-02-17 | 2024-02-21 | 6,944 | — | $0 | 48,612 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-02-17 | 2024-02-21 | 20,833 | — | $0 | 62,500 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2024-02-17 | 2024-02-21 | 54,415 | — | $0 | 236,091 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2024-02-14 | 2024-02-16 | 58,356 | $15.01 | $875.9K | 181,676 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2024-02-11 | 2024-02-13 | 83,333 | — | $0 | 83,333 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award | 2024-02-11 | 2024-02-13 | 122,500 | — | $0 | 240,032 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2024-02-01 | 2024-02-05 | 700 | $16.81 | $11.8K | 117,532 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2024-02-01 | 2024-02-05 | 9,300 | $16.18 | $150.5K | 118,232 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2023-12-27 | 2023-12-28 | 30,000 | $12.02 | $360.6K | 127,532 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2023-11-20 | 2023-11-21 | 14,807 | $8.23 | $121.9K | 157,532 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-11-17 | 2023-11-21 | 5,805 | — | $0 | 58,050 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-11-17 | 2023-11-21 | 20,833 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-11-17 | 2023-11-21 | 6,945 | — | $0 | 55,556 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2023-11-17 | 2023-11-21 | 33,583 | — | $0 | 172,339 | SEC↗ |
| KALV KalVista Pharmaceuticals, | G Gift | 2023-10-30 | 2023-11-01 | 8,000 | — | $0 | 138,756 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2023-08-18 | 2023-08-21 | 14,876 | $10.73 | $159.6K | 146,756 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-08-17 | 2023-08-21 | 20,833 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-08-17 | 2023-08-21 | 5,805 | — | $0 | 63,855 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-08-17 | 2023-08-21 | 6,944 | — | $0 | 62,501 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2023-08-17 | 2023-08-21 | 33,582 | — | $0 | 161,632 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2023-05-18 | 2023-05-19 | 5,627 | $10.14 | $57.1K | 128,050 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-05-17 | 2023-05-19 | 6,945 | — | $0 | 69,445 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-05-17 | 2023-05-19 | 5,805 | — | $0 | 69,660 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2023-05-17 | 2023-05-19 | 12,750 | — | $0 | 133,677 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-02-17 | 2023-05-22 | 6,944 | — | $0 | 76,390 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-02-17 | 2023-02-23 | 5,805 | — | $0 | 75,465 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-02-17 | 2023-02-23 | 6,944 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2023-02-17 | 2023-02-23 | 12,749 | — | $0 | 127,627 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2023-02-17 | 2023-02-23 | 6,700 | $7.66 | $51.3K | 120,927 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2023-01-11 | 2023-05-19 | 83,334 | — | $0 | 83,334 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2022-11-18 | 2022-11-21 | 1,785 | $5.44 | $9.7K | 114,878 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2022-11-17 | 2022-11-21 | 5,805 | — | $0 | 81,270 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2022-11-17 | 2022-11-21 | 5,805 | — | $0 | 116,663 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2022-09-02 | 2022-09-07 | 1,320 | $17.01 | $22.5K | 110,858 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2022-08-17 | 2022-08-19 | 5,805 | — | $0 | 91,083 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2022-08-17 | 2022-08-19 | 1,797 | $14.96 | $26.9K | 112,178 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2022-08-17 | 2022-08-19 | 5,805 | — | $0 | 113,975 | SEC↗ |
| KALV KalVista Pharmaceuticals, | G Gift | 2022-07-02 | 2022-09-07 | 6,500 | — | $0 | 112,178 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2022-05-17 | 2022-05-19 | 92,880 | — | $0 | 92,880 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2022-05-17 | 2022-05-19 | 61,920 | — | $0 | 61,920 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2022-03-09 | 2022-03-11 | 10,000 | $17.07 | $170.7K | 114,670 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2021-10-01 | 2021-10-04 | 10,000 | $17.18 | $171.8K | 124,670 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2021-07-01 | 2021-07-02 | 5,650 | $24.35 | $137.6K | 134,670 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2021-07-01 | 2021-07-02 | 4,350 | $23.88 | $103.9K | 140,320 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2021-06-17 | 2021-06-22 | 1,067 | $30.04 | $32.1K | 144,670 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2021-06-09 | 2021-06-11 | 8,933 | $30.05 | $268.4K | 145,737 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2021-05-26 | 2021-05-28 | 200,000 | — | $0 | 200,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | G Gift | 2021-04-29 | 2021-05-28 | 4,750 | — | $0 | 154,670 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2021-04-01 | 2021-04-05 | 700 | $26.22 | $18.4K | 168,720 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2021-04-01 | 2021-04-05 | 800 | $28.11 | $22.5K | 159,420 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2021-04-01 | 2021-04-05 | 8,500 | $27.48 | $233.6K | 160,220 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2021-02-23 | 2021-02-25 | 7,218 | $33.73 | $243.5K | 171,702 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2021-02-23 | 2021-02-25 | 1,575 | $32.94 | $51.9K | 170,127 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2021-02-23 | 2021-02-25 | 707 | $31.87 | $22.5K | 169,420 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2021-02-23 | 2021-02-25 | 500 | $35.40 | $17.7K | 178,920 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2021-02-07 | 2021-02-08 | 40,000 | — | $0 | 40,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2021-02-07 | 2021-02-08 | 75,000 | — | $0 | 75,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2021-01-04 | 2021-01-06 | 814 | $18.85 | $15.3K | 185,420 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2021-01-04 | 2021-01-06 | 9,186 | $18.13 | $166.5K | 186,234 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2020-12-16 | 2020-12-18 | 140,000 | — | $0 | 140,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | G Gift | 2020-10-29 | 2021-01-06 | 6,000 | — | $0 | 179,420 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2020-10-21 | 2020-10-22 | 3,693 | $19.01 | $70.2K | 195,420 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2020-10-21 | 2020-10-22 | 5,800 | $17.48 | $101.4K | 212,165 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2020-10-21 | 2020-10-22 | 13,052 | $18.51 | $241.6K | 199,113 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2020-10-20 | 2020-10-22 | 4,776 | $18.01 | $86.0K | 217,965 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2020-10-20 | 2020-10-22 | 11,218 | $17.27 | $193.7K | 222,741 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2020-10-16 | 2020-10-20 | 1,261 | $17.01 | $21.4K | 236,959 | SEC↗ |
| KALV KalVista Pharmaceuticals, | G Gift | 2020-04-29 | 2020-10-20 | 3,000 | — | $0 | 233,959 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2020-02-05 | 2020-02-07 | 200 | $17.05 | $3.4K | 238,220 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2019-12-20 | 2019-12-26 | 2,300 | $17.02 | $39.1K | 238,420 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2019-12-16 | 2019-12-16 | 5,400 | $17.06 | $92.1K | 240,720 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2019-12-13 | 2019-12-16 | 2,200 | $17.06 | $37.5K | 246,120 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2019-12-12 | 2019-12-16 | 100 | $17.00 | $1.7K | 248,320 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2019-07-15 | 2019-07-17 | 10,000 | $17.04 | $170.4K | 248,510 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2019-05-15 | 2019-05-17 | 67,500 | — | $0 | 67,500 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2019-04-15 | 2019-04-23 | 9,700 | $24.76 | $240.2K | 258,810 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2019-04-15 | 2019-04-23 | 300 | $25.92 | $7.8K | 258,510 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2019-03-14 | 2019-03-15 | 3,000 | $30.16 | $90.5K | 268,510 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2019-01-14 | 2019-01-16 | 901 | $19.86 | $17.9K | 271,510 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2019-01-14 | 2019-01-16 | 9,099 | $19.28 | $175.4K | 272,411 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2018-09-18 | 2018-09-20 | 150,000 | — | $0 | 150,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2018-06-04 | 2018-06-06 | 130,800 | — | $0 | 130,800 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2017-05-25 | 2017-05-26 | 187,000 | — | $0 | 187,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award | 2016-11-21 | 2016-11-28 | 281,420 | — | $0 | 281,420 | SEC↗ |